Tag: Sofosbuvir-velpatasvir

1. HCV-naive patients in need of heart or lung transplants who received organs from HCV-positive donors and were treated with sofobuvir-velpatasvir demonstrated intact graft function with undetectable viral loads during post-surgical follow up. 2. No treatment-related serious adverse effects were noted in the study population. Evidence Rating Level: 2 (Good) Study Rundown:...
1. Among patients with hepatitis C virus (HCV) genotype 2 or 3, 12 weeks of treatment with a once-daily, fixed-dose, combination tablet of sofosbuvir-velpatasvir resulted in rates of sustained virologic response compared to those treated with standard therapy. 2. The results from this study provide the potential for using...